WDNA ETF holdings (CBOE) - Page 4 | MetaTrader

Abrir gráfico completo Full chart

Visão geral Todos os ativos Mapa de calor

Principais ativos Market Value Shares Weight %

HALO Halozyme Therapeutics Inc 16.9 K 251.0 0.7%

IOVA Iovance Biotherapeutics Inc 16.3 K 5 980.0 0.6%

SDGR Schrodinger Inc/United States 15.2 K 849.0 0.6%

BBIO Bridgebio Pharma Inc 15.1 K 198.0 0.6%

RARE Ultragenyx Pharmaceutical Inc 14.5 K 630.0 0.6%

RVMD Revolution Medicines Inc 13.9 K 174.0 0.5%

Genus PLC 12.6 K 361.0 0.5%

Verbio SE 12.5 K 504.0 0.5%

TECH Bio-Techne Corp 12.5 K 213.0 0.5%

GERN Geron Corp 12.0 K 9 117.0 0.5%

ILMN Illumina Inc 11.8 K 90.0 0.5%

ALNY Alnylam Pharmaceuticals Inc 11.5 K 29.0 0.5%

RXRX Recursion Pharmaceuticals Inc 11.1 K 2 713.0 0.4%

Oxford Nanopore Technologies P 10.9 K 6 329.0 0.4%

SRPT Sarepta Therapeutics Inc 10.2 K 473.0 0.4%

GPRE Green Plains Inc 9 349.2 954.0 0.4%

PACB Pacific Biosciences of Califor 9 000.3 4 813.0 0.4%

TSN Tyson Foods Inc 8 382.7 143.0 0.3%

TMO Thermo Fisher Scientific Inc 8 112.3 14.0 0.3%

RCKT Rocket Pharmaceuticals Inc 8 101.1 2 308.0 0.3%

1
2
3
4
5

Notícias

First Quarter Earnings: Sharpening Sector Divergence

3 Reasons To Stick With Growth Stocks In Rotating Markets

Seeking Innovation Beyond Tech? Insight On Healthcare Stocks

Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts

What's The Dominant Trend In Earnings: AI Or Geopolitics?

Medical Technology Stocks: Innovation Endures As Valuations Reset

AI And The Future Of Healthcare

Global PMI: Tracking The Sectors Hit Hardest By The Middle East War

Can Forgotten Biotech Break Out?

Concerns Shift From Obsolescence To Oil

A Dog, A Diagnosis And A Different Way To Understand AI

CDT Insider Sentiment March 2026: The Probability Race And Barbell Strategies